Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly.

@article{Lam1993SerumAC,
  title={Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly.},
  author={K S Lam and Richard Pang and Edward Janus and Annie Wai-Chee Kung and Conrad Wang},
  journal={Atherosclerosis},
  year={1993},
  volume={104 1-2},
  pages={183-8}
}
Untreated acromegaly is associated with an increased cardiovascular morbidity and mortality. The contribution of altered lipid metabolism remains unclear. We investigated the relationship between serum apolipoprotein(a) (apo(a)) and growth hormone (GH) levels in 15 patients with acromegaly before and during treatment with octreotide, a long-acting somatostatin analogue, 288-600 micrograms/day s.c., for 6 months. Before treatment serum apo(a) was significantly elevated in acromegalic patients… CONTINUE READING